| Year |
Citation |
Score |
| 2019 |
Lagae L, Sullivan J, Knupp K, Laux L, Polster T, Nikanorova M, Devinsky O, Cross JH, Guerrini R, Talwar D, Miller I, Farfel G, Galer BS, Gammaitoni A, Mistry A, et al. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). PMID 31862249 DOI: 10.1016/S0140-6736(19)32500-0 |
0.307 |
|
| 2016 |
Schoonjans A, Paelinck BP, Marchau F, Gunning B, Gammaitoni A, Galer BS, Lagae L, Ceulemans B. Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients. European Journal of Neurology. 24: 309-314. PMID 27790834 DOI: 10.1111/ene.13195 |
0.304 |
|
| 2015 |
Argoff C, Arnstein P, Stanos S, Robinson CY, Galer BS, Gould E, Gammaitoni A. Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate. Journal of Opioid Management. 11: 417-24. PMID 26535969 DOI: 10.5055/jom.2015.0291 |
0.6 |
|
| 2015 |
Nalamachu S, deLeon-Casasola OA, Robinson CY, Galer BS, Gould E, Gammaitoni A. An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release Hydrocodone. Pain Medicine (Malden, Mass.). PMID 26301791 DOI: 10.1111/pme.12831 |
0.401 |
|
| 2015 |
Gammaitoni AR, Trudeau JJ, Radnovich R, Galer BS, Jensen MP. Predicting Response to Subacromial Injections and Lidocaine/Tetracaine Patch from Pretreatment Pain Quality in Patients with Shoulder Impingement Syndrome. Pain Medicine (Malden, Mass.). 16: 1333-40. PMID 25917860 DOI: 10.1111/Pme.12758 |
0.606 |
|
| 2015 |
Jensen MP, Trudeau JJ, Radnovich R, Galer BS, Gammaitoni AR. The pain quality response profile of a corticosteroid injections and heated lidocaine/tetracaine patch in the treatment of shoulder impingement syndrome. The Clinical Journal of Pain. 31: 342-8. PMID 25329142 DOI: 10.1097/Ajp.0000000000000130 |
0.583 |
|
| 2015 |
Nalamachu S, deLeon-Casasola OA, Robinson CY, Galer BS, Gould E, Gammaitoni A. An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release Hydrocodone Pain Medicine (United States). DOI: 10.1111/pme.12831 |
0.431 |
|
| 2013 |
Jensen MP, Johnson LE, Gertz KJ, Galer BS, Gammaitoni AR. The words patients use to describe chronic pain: implications for measuring pain quality. Pain. 154: 2722-8. PMID 23933183 DOI: 10.1016/j.pain.2013.08.003 |
0.636 |
|
| 2013 |
Gammaitoni AR, Goitz HT, Marsh S, Marriott TB, Galer BS. Heated lidocaine/tetracaine patch for treatment of patellar tendinopathy pain. Journal of Pain Research. 6: 565-70. PMID 23888118 DOI: 10.2147/JPR.S46239 |
0.588 |
|
| 2013 |
Jensen MP, Lin CP, Kupper AE, Galer BS, Gammaitoni AR. Cognitive testing and revision of the pain quality assessment scale. The Clinical Journal of Pain. 29: 400-10. PMID 23247001 DOI: 10.1097/AJP.0b013e318260857d |
0.572 |
|
| 2013 |
Gammaitoni AR, Smugar SS, Jensen MP, Galer BS, Bolognese JA, Alon A, Hewitt DJ. Predicting response to pregabalin from pretreatment pain quality: clinical applications of the pain quality assessment scale. Pain Medicine (Malden, Mass.). 14: 526-32. PMID 22759088 DOI: 10.1111/j.1526-4637.2012.01423.x |
0.586 |
|
| 2012 |
Oaklander AL, Wilson PR, Moskovitz PA, Manning DC, Lubenow T, Levine JD, Harden RN, Galer BS, Cooper MS, Bruehl S, Broatch J, Berde C, Bennett GJ. Response to "A new definition of neuropathic pain". Pain. 153: 934-5; author reply . PMID 22342073 DOI: 10.1016/J.Pain.2012.01.012 |
0.67 |
|
| 2012 |
Jensen MP, Gammaitoni AR, Bolognese JA, Alon A, Smugar SS, Galer BS, Hewitt DJ. The pain quality response profile of pregabalin in the treatment of neuropathic pain. The Clinical Journal of Pain. 28: 683-6. PMID 22156827 DOI: 10.1097/AJP.0b013e31823f9e64 |
0.648 |
|
| 2011 |
Lin CP, Kupper AE, Gammaitoni AR, Galer BS, Jensen MP. Frequency of chronic pain descriptors: implications for assessment of pain quality. European Journal of Pain (London, England). 15: 628-33. PMID 21216641 DOI: 10.1016/j.ejpain.2010.11.006 |
0.641 |
|
| 2011 |
Hewitt DJ, Ho TW, Galer B, Backonja M, Markovitz P, Gammaitoni A, Michelson D, Bolognese J, Alon A, Rosenberg E, Herman G, Wang H. Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain. Pain. 152: 514-21. PMID 21185118 DOI: 10.1016/j.pain.2010.10.050 |
0.611 |
|
| 2011 |
Dworkin RH, Jensen MP, Gould E, Jones BA, Xiang Q, Galer BS, Gammaitoni AR. Treatment satisfaction in osteoarthritis and chronic low back pain: the role of pain, physical and emotional functioning, sleep, and adverse events. The Journal of Pain : Official Journal of the American Pain Society. 12: 416-24. PMID 20869325 DOI: 10.1016/j.jpain.2010.07.009 |
0.589 |
|
| 2011 |
Galer BS. A comparative subjective assessment study of PENNSAID® and Voltaren Gel®, two topical formulations of diclofenac sodium. Pain Practice : the Official Journal of World Institute of Pain. 11: 252-60. PMID 20854305 DOI: 10.1111/j.1533-2500.2010.00420.x |
0.311 |
|
| 2011 |
Gammaitoni A, Jensen M, Bolognese J, Smugar S, Mehta A, Alon A, Galer B, Hewitt D. T269 PREDICTING RESPONSE TO PREGABALIN IN NEUROPATHIC PAIN - RESULTS FROM AN ENRICHED ENROLLMENT RANDOMIZED WITHDRAWAL TRIAL European Journal of Pain Supplements. 5: 56-56. DOI: 10.1016/S1754-3207(11)70187-0 |
0.419 |
|
| 2011 |
Smugar S, Gammaitoni A, Jensen M, Bolognese J, Alon A, Mehta A, Galer B, Hewitt D. T268 LONGITUDINAL RESPONSE TO PREGABALIN IN NEUROPATHIC PAIN: AN ANALYSIS FROM AN ENRICHED ENROLLMENT RANDOMIZED WITHDRAWAL TRIAL European Journal of Pain Supplements. 5: 55-56. DOI: 10.1016/S1754-3207(11)70186-9 |
0.432 |
|
| 2010 |
Jensen MP, Gould EM, Victor TW, Gammaitoni AR, White RE, Galer BS. The relationship of changes in pain quality to pain interference and sleep quality. The Journal of Pain : Official Journal of the American Pain Society. 11: 782-8. PMID 20338817 DOI: 10.1016/j.jpain.2009.11.009 |
0.623 |
|
| 2010 |
Waterman C, Victor TW, Jensen MP, Gould EM, Gammaitoni AR, Galer BS. The assessment of pain quality: an item response theory analysis. The Journal of Pain : Official Journal of the American Pain Society. 11: 273-9. PMID 20211439 DOI: 10.1016/j.jpain.2009.07.014 |
0.594 |
|
| 2009 |
Gould EM, Jensen MP, Victor TW, Gammaitoni AR, White RE, Galer BS. The pain quality response profile of oxymorphone extended release in the treatment of low back pain. The Clinical Journal of Pain. 25: 116-22. PMID 19333156 DOI: 10.1097/AJP.0b013e3181817ac8 |
0.646 |
|
| 2008 |
Victor TW, Jensen MP, Gammaitoni AR, Gould EM, White RE, Galer BS. The dimensions of pain quality: factor analysis of the Pain Quality Assessment Scale. The Clinical Journal of Pain. 24: 550-5. PMID 18574365 DOI: 10.1097/AJP.0b013e31816b1058 |
0.633 |
|
| 2007 |
Dworkin RH, Jensen MP, Gammaitoni AR, Olaleye DO, Galer BS. Symptom profiles differ in patients with neuropathic versus non-neuropathic pain. The Journal of Pain : Official Journal of the American Pain Society. 8: 118-26. PMID 16949878 DOI: 10.1016/j.jpain.2006.06.005 |
0.652 |
|
| 2006 |
Jensen MP, Gammaitoni AR, Olaleye DO, Oleka N, Nalamachu SR, Galer BS. The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome. The Journal of Pain : Official Journal of the American Pain Society. 7: 823-32. PMID 17074624 DOI: 10.1016/j.jpain.2006.04.003 |
0.644 |
|
| 2006 |
Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS. Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning? The Journal of Pain : Official Journal of the American Pain Society. 7: 644-53. PMID 16942950 DOI: 10.1016/j.jpain.2006.02.012 |
0.645 |
|
| 2006 |
Kivitz A, Ma C, Ahdieh H, Galer BS. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clinical Therapeutics. 28: 352-64. PMID 16750450 DOI: 10.1016/j.clinthera.2006.03.008 |
0.559 |
|
| 2005 |
Galer BS. Response to: response to letter regarding 'impaired self-perception of the hand in complex regional pain syndrome'. Pain. 117: 242; author reply 24. PMID 16099100 DOI: 10.1016/j.pain.2005.06.026 |
0.475 |
|
| 2005 |
Galer BS, Lee D, Ma T, Nagle B, Schlagheck TG. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain. 115: 284-95. PMID 15911155 DOI: 10.1016/j.pain.2005.03.004 |
0.42 |
|
| 2005 |
Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. The Journal of Pain : Official Journal of the American Pain Society. 6: 98-106. PMID 15694876 DOI: 10.1016/j.jpain.2004.11.002 |
0.646 |
|
| 2005 |
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 113: 9-19. PMID 15621359 DOI: 10.1016/J.Pain.2004.09.012 |
0.502 |
|
| 2005 |
Galer B, Kivitz A, Fairfax M, Sheldon E, Oleka N, Gammaitoni A. A randomized, open-label study comparing the efficacy and safety of lidocaine patch 5% with celecoxib 200 mg in patients with pain from osteoarthritis of the knee The Journal of Pain. 6: S51. DOI: 10.1016/J.JPAIN.2005.01.198 |
0.61 |
|
| 2005 |
Galer B, Oleka N, Gammaitoni A. Lidocaine patch 5% improves outcomes for low-back pain and osteoarthritis patients receiving COX-2-selective or traditional NSAID therapy for pain relief The Journal of Pain. 6: S50. DOI: 10.1016/J.JPAIN.2005.01.195 |
0.604 |
|
| 2004 |
Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Current Medical Research and Opinion. 20: S21-8. PMID 15563743 DOI: 10.1185/030079904X12960 |
0.636 |
|
| 2004 |
Gammaitoni AR, Galer BS, Onawola R, Jensen MP, Argoff CE. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Current Medical Research and Opinion. 20: S13-9. PMID 15563742 DOI: 10.1185/030079904X12951 |
0.606 |
|
| 2004 |
Galer BS, Gammaitoni AR, Oleka N, Jensen MP, Argoff CE. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Current Medical Research and Opinion. 20: S5-12. PMID 15563741 DOI: 10.1185/030079904X12933 |
0.589 |
|
| 2004 |
Galer BS, Sheldon E, Patel N, Codding C, Burch F, Gammaitoni AR. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Current Medical Research and Opinion. 20: 1455-8. PMID 15383194 DOI: 10.1185/030079904X2754 |
0.647 |
|
| 2004 |
Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs. 64: 937-47. PMID 15101784 DOI: 10.2165/00003495-200464090-00002 |
0.523 |
|
| 2004 |
Gammaitoni A, Hale M, Linn R, Galer B. Topical analgesics The Journal of Pain. 5: S83. DOI: 10.1016/j.jpain.2004.02.300 |
0.322 |
|
| 2004 |
Gammaitoni A, Burch F, Codding C, Patel N, Sheldon E, Galer B. D. Treatment approaches (medical/interventional)Topical analgesics: Lidocaine patch 5% effectively treats pain qualities in osteoarthritis: results of a 2-week, prospective, open-label trial The Journal of Pain. 5. DOI: 10.1016/J.Jpain.2004.02.298 |
0.493 |
|
| 2004 |
Gammaitoni A, Gimbel J, Hale M, Linn R, Galer B. Topical analgesics The Journal of Pain. 5: S82. DOI: 10.1016/j.jpain.2004.02.297 |
0.426 |
|
| 2003 |
Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 106: 337-45. PMID 14659516 DOI: 10.1016/J.Pain.2003.08.001 |
0.492 |
|
| 2003 |
Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Archives of Neurology. 60: 1524-34. PMID 14623723 DOI: 10.1001/Archneur.60.11.1524 |
0.626 |
|
| 2003 |
Oaklander AL, Bowsher D, Galer B, Haanpää M, Jensen MP. Herpes zoster itch: Preliminary epidemiologic data Journal of Pain. 4: 338-343. PMID 14622691 DOI: 10.1016/S1526-5900(03)00637-0 |
0.501 |
|
| 2003 |
Gammaitoni AR, Galer BS, Lacouture P, Domingos J, Schlagheck T. Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain. Pain Medicine (Malden, Mass.). 4: 21-30. PMID 12873275 DOI: 10.1046/j.1526-4637.2003.03002.x |
0.635 |
|
| 2003 |
Gammaitoni AR, Galer BS, Bulloch S, Lacouture P, Caruso F, Ma T, Schlagheck T. Randomized, double-blind, placebo-controlled comparison of the analgesic efficacy of oxycodone 10 mg/acetaminophen 325 mg versus controlled-release oxycodone 20 mg in postsurgical pain. Journal of Clinical Pharmacology. 43: 296-304. PMID 12638399 DOI: 10.1177/0091270003251147 |
0.556 |
|
| 2003 |
Galer BS, Gammaitoni AR. More than 7 years of consistent neuropathic pain relief in geriatric patients. Archives of Internal Medicine. 163: 628. PMID 12622611 DOI: 10.1001/archinte.163.5.628 |
0.614 |
|
| 2003 |
Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. Journal of Clinical Pharmacology. 43: 111-7. PMID 12616661 DOI: 10.1177/0091270002239817 |
0.355 |
|
| 2003 |
Hart-Gouleau S, Gammaitoni AR, Galer BS, Domingos J, Dworkin R. Poster 97 Archives of Physical Medicine and Rehabilitation. 84: E22. DOI: 10.1016/S0003-9993(03)00639-7 |
0.646 |
|
| 2003 |
Galer BS, Gammaitoni AR, Burch F, Codding C, Patel N, Sheldon E. Poster 96 Archives of Physical Medicine and Rehabilitation. 84: E22. DOI: 10.1016/S0003-9993(03)00638-5 |
0.654 |
|
| 2002 |
Wallace MS, Rowbotham MC, Katz NP, Dworkin RH, Dotson RM, Galer BS, Rauck RL, Backonja MM, Quessy SN, Meisner PD. A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology. 59: 1694-700. PMID 12473754 DOI: 10.1212/01.Wnl.0000036273.98213.34 |
0.604 |
|
| 2002 |
Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. The Clinical Journal of Pain. 18: 297-301. PMID 12218500 DOI: 10.1097/00002508-200209000-00004 |
0.613 |
|
| 2002 |
Bruehl S, Harden RN, Galer BS, Saltz S, Backonja M, Stanton-Hicks M. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain. 95: 119-24. PMID 11790474 DOI: 10.1016/S0304-3959(01)00387-6 |
0.559 |
|
| 2001 |
Carter GT, Galer BS. Advances in the management of neuropathic pain. Physical Medicine and Rehabilitation Clinics of North America. 12: 447-59. PMID 11345017 |
0.557 |
|
| 2001 |
Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open‐label study. (Department of Pain Medicine and Palliative Care, Beth Lsrael Medical Center, New York, NY) Clin J Pain 2000;16:205–208. Pain Practice. 1: 204-204. DOI: 10.1046/J.1533-2500.2001.001002204.X |
0.665 |
|
| 2001 |
Carter GT, Galer BS. Advances in the Diagnosis and Management of Peripheral Nerve Disease Physical Medicine and Rehabilitation Clinics of North America. 12: 447-459. DOI: 10.1016/S1047-9651(18)30801-5 |
0.605 |
|
| 2000 |
Galer BS, Twilling LL, Harle J, Cluff RS, Friedman E, Rowbotham MC. Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions. Neurology. 55: 971-5. PMID 11061253 DOI: 10.1212/Wnl.55.7.971 |
0.597 |
|
| 2000 |
Galer BS, Henderson J, Perander J, Jensen MP. Course of symptoms and quality of life measurement in Complex Regional Pain Syndrome: a pilot survey. Journal of Pain and Symptom Management. 20: 286-92. PMID 11027911 DOI: 10.1016/S0885-3924(00)00183-4 |
0.592 |
|
| 2000 |
Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. The Clinical Journal of Pain. 16: 205-8. PMID 11014393 DOI: 10.1097/00002508-200009000-00005 |
0.665 |
|
| 2000 |
Galer BS, Rowbotham M, Perander J, Devers A, Friedman E. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. Journal of Pain and Symptom Management. 19: 287-94. PMID 10799795 DOI: 10.1016/S0885-3924(00)00125-1 |
0.603 |
|
| 2000 |
Cramer GW, Galer BS, Mendelson MA, Thompson GD. A drug use evaluation of selected opioid and nonopioid analgesics in the nursing facility setting. Journal of the American Geriatrics Society. 48: 398-404. PMID 10798466 DOI: 10.1111/J.1532-5415.2000.Tb04697.X |
0.61 |
|
| 2000 |
Galer BS. Hemisensory impairment in patients with complex regional pain syndrome. Pain. 84: 113. PMID 10681242 DOI: 10.1016/S0304-3959(99)00178-5 |
0.555 |
|
| 2000 |
Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Research and Clinical Practice. 47: 123-8. PMID 10670912 DOI: 10.1016/S0168-8227(99)00112-6 |
0.6 |
|
| 2000 |
Galer BS. PAIN 4041: Comment on Rommel et al., PAIN 80 (1999) 95-101 [3] Pain. 84: 113. |
0.479 |
|
| 2000 |
Dworkin RH, Galer BS, Perkins FM. Mechanism and Treatment of Neuropathic Pain: Introduction Clinical Journal of Pain. 16: S1. |
0.538 |
|
| 1999 |
Harden RN, Bruehl S, Galer BS, Saltz S, Bertram M, Backonja M, Gayles R, Rudin N, Bhugra MK, Stanton-Hicks M. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain. 83: 211-9. PMID 10534592 DOI: 10.1016/S0304-3959(99)00104-9 |
0.524 |
|
| 1999 |
Galer BS, Jensen M. Neglect-like symptoms in complex regional pain syndrome: results of a self-administered survey. Journal of Pain and Symptom Management. 18: 213-7. PMID 10517043 DOI: 10.1016/S0885-3924(99)00076-7 |
0.413 |
|
| 1999 |
Rashiq S, Galer BS. Proximal myofascial dysfunction in complex regional pain syndrome: a retrospective prevalence study. The Clinical Journal of Pain. 15: 151-3. PMID 10382930 DOI: 10.1097/00002508-199906000-00013 |
0.489 |
|
| 1999 |
Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, Gayles R, Rudin N, Bhugra MK, Stanton-Hicks M. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain. 81: 147-54. PMID 10353502 DOI: 10.1016/S0304-3959(99)00011-1 |
0.521 |
|
| 1999 |
Allen G, Galer BS, Schwartz L. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain. 80: 539-44. PMID 10342415 DOI: 10.1016/S0304-3959(98)00246-2 |
0.626 |
|
| 1999 |
Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 80: 533-8. PMID 10342414 DOI: 10.1016/S0304-3959(98)00244-9 |
0.512 |
|
| 1999 |
Galer BS, Keran C, Frisinger M. Pain medicine education among American neurologists: a need for improvement. Neurology. 52: 1710-2. PMID 10331709 DOI: 10.1212/Wnl.52.8.1710 |
0.561 |
|
| 1999 |
Shibata M, Nakao K, Galer BS, Shimizu T, Taniguchi H, Uchida T. A case of reflex sympathetic dystrophy (complex regional pain syndrome, type I) resolved by cerebral contusion. Pain. 79: 313-5. PMID 10068177 DOI: 10.1016/S0304-3959(98)00182-1 |
0.512 |
|
| 1998 |
Carter GT, Jensen MP, Galer BS, Kraft GH, Crabtree LD, Beardsley RM, Abresch RT, Bird TD. Neuropathic pain in Charcot-Marie-Tooth disease. Archives of Physical Medicine and Rehabilitation. 79: 1560-4. PMID 9862301 DOI: 10.1016/S0003-9993(98)90421-X |
0.646 |
|
| 1998 |
Galer BS. Painful polyneuropathy. Neurologic Clinics. 16: 791-812. PMID 9767063 DOI: 10.1016/S0733-8619(05)70098-0 |
0.571 |
|
| 1998 |
Backonja MM, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurologic Clinics. 16: 775-90. PMID 9767062 DOI: 10.1016/S0733-8619(05)70097-9 |
0.622 |
|
| 1998 |
Stang P, Von Korff M, Galer BS. Reduced labor force participation among primary care patients with headache. Journal of General Internal Medicine. 13: 296-302. PMID 9613884 DOI: 10.1046/j.1525-1497.1998.00094.x |
0.468 |
|
| 1998 |
Galer BS, Bruehl S, Harden RN. IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. International Association for the Study of Pain. The Clinical Journal of Pain. 14: 48-54. PMID 9535313 DOI: 10.1097/00002508-199803000-00007 |
0.54 |
|
| 1997 |
Galer BS, Schwartz L, Turner JA. Do patient and physician expectations predict response to pain-relieving procedures? The Clinical Journal of Pain. 13: 348-51. PMID 9430816 DOI: 10.1097/00002508-199712000-00013 |
0.635 |
|
| 1997 |
Galer BS. Comment on Bruehl et al., PAIN, 67 (1996) 107-114. Pain. 71: 209-10. PMID 9211486 DOI: 10.1097/00006396-199706000-00020 |
0.451 |
|
| 1997 |
Galer BS. Myofascial pain and fibromyalgia syndrome. Neurology. 48: 1739; author reply 1. PMID 9191809 |
0.535 |
|
| 1997 |
Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 48: 332-8. PMID 9040716 DOI: 10.1212/WNL.48.2.332 |
0.629 |
|
| 1996 |
Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. 65: 39-44. PMID 8826488 DOI: 10.1016/0304-3959(95)00146-8 |
0.536 |
|
| 1996 |
Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. Journal of Pain and Symptom Management. 12: 161-7. PMID 8803379 DOI: 10.1016/0885-3924(96)00126-1 |
0.562 |
|
| 1996 |
Galer BS. Pain management: Theory and practice: Contemporary neurology series, vol 48 Russell K. Portenoy and Ronald M. Kanner, Philadelphia, FA Davis, 1996 357 pp, illustrated, $99,00 Annals of Neurology. 40: 822-823. DOI: 10.1002/ana.410400530 |
0.328 |
|
| 1995 |
Von Korff M, Galer BS, Stang P. Chronic use of symptomatic headache medications. Pain. 62: 179-86. PMID 8545143 DOI: 10.1016/0304-3959(94)00263-E |
0.3 |
|
| 1995 |
Galer BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 45: S17-25; discussion S. PMID 8538882 DOI: 10.1212/WNL.45.12_Suppl_9.S17 |
0.622 |
|
| 1995 |
Galer BS. Peak pain relief is delayed and duration of relief is extended following intravenous phentolamine infusion. Preliminary report. Regional Anesthesia. 20: 444-7. PMID 8519723 DOI: 10.1136/Rapm-00115550-199520050-00013 |
0.621 |
|
| 1995 |
Galer BS, Butler S, Jensen MP. Case reports and hypothesis: a neglect-like syndrome may be responsible for the motor disturbance in reflex sympathetic dystrophy (Complex Regional Pain Syndrome-1). Journal of Pain and Symptom Management. 10: 385-91. PMID 7673771 DOI: 10.1016/0885-3924(95)00061-3 |
0.528 |
|
| 1994 |
Fitzgibbon DR, Galer BS. The efficacy of opioids in cancer pain syndromes. Pain. 58: 429-31. PMID 7838593 DOI: 10.1016/0304-3959(94)90138-4 |
0.589 |
|
| 1994 |
Galer BS. Painful polyneuropathy: diagnosis, pathophysiology, and management. Seminars in Neurology. 14: 237-46. PMID 7701124 DOI: 10.1055/s-2008-1041082 |
0.539 |
|
| 1993 |
Galer BS, Miller KV, Rowbotham MC. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology. 43: 1233-5. PMID 8170571 DOI: 10.1212/Wnl.43.6.1233 |
0.593 |
|
| 1993 |
Galer BS. Opioids and chronic nonmalignant pain Aps Journal. 2: 207. DOI: 10.1016/S1058-9139(05)80092-0 |
0.453 |
|
| 1992 |
Galer BS, Rowbotham MC, Von Miller K, Walton A, Fields HL. Treatment of inflammatory, neuropathic and sympathetically maintained pain in a patient with Sjögren's syndrome. Pain. 50: 205-8. PMID 1408318 DOI: 10.1016/0304-3959(92)90163-6 |
0.686 |
|
| 1992 |
Galer BS, Coyle N, Pasternak GW, Portenoy RK. Individual variability in the response to different opioids: report of five cases. Pain. 49: 87-91. PMID 1375728 DOI: 10.1016/0304-3959(92)90192-E |
0.301 |
|
| 1991 |
Galer BS, Lipton RB, Kaplan R, Kaplan JG, Arezzo J, Portenoy RK. Bilateral burning foot pain: monitoring of pain, sensation, and autonomic function during successful treatment with sympathetic blockade. Journal of Pain and Symptom Management. 6: 92-7. PMID 2007797 DOI: 10.1016/0885-3924(91)90523-7 |
0.49 |
|
| 1991 |
Galer BS, Portenoy RK. Acute herpetic and postherpetic neuralgia: clinical features and management. The Mount Sinai Journal of Medicine, New York. 58: 257-66. PMID 1875964 |
0.511 |
|
| Show low-probability matches. |